Porous biomaterials composed of highly purified collagen and solubilised elastin were prepared by freezing and lyophilisation and studied by subcutaneous implantation in young Sprague Dawley rats. The scaffolds, containing depots of soluble elastin, showed no calcification in this sensitive calcification model, in contrast to scaffolds containing insoluble elastin fibres. Scaffolds induced the formation of blood vessels and promoted elastic fibre synthesis as was shown with specific antibodies.
Introduction
Elastin is the prime protein in tissues that display elasticity of e.g. lung, aorta, and skin. Upon injury, elastic fibres are not readily replaced which causes a delay in tissue regeneration. Incorporation of solubilised elastin (obtained from insoluble elastin fibres by hydrolysis) into biomaterials may improve tissue regeneration, since solubilised elastin is able to promote fibroblast proliferation as well as elastin synthesis [1] [2] [3] .
Experimental methods
Elastin fibres were hydrolysed by means of oxalic acid [4] . Three different scaffolds were prepared composed of: collagen (COL) [5, 6] , collagen + elastin fibres (COL-EL fibre ) [7, 8] , and collagen + solubilised elastin (COL-EL sol ). All scaffolds were chemically crosslinked and morphologically and biochemically characterised. Scaffolds were subcutaneously implanted in 3 weeks old Sprague Dawley rats, and retrieved after 3, 7, and 21 days. Paraffin sections of explants were stained with haematoxylin-eosin; elastin and collagen were stained according to Elastin Van Gieson; calcium deposits were visualized by Von Kossa staining. Cryo-sections were stained for type IV collagen, rat elastin and the elastin fibre-associated molecule fibrillin using specific antibodies (immunohistochemistry).
Results and discussion
Porous biomaterials composed of collagen and solubilised elastin could be prepared by freezing and lyophilising. Solubilised elastin was associated with the collagen fibrils of the scaffolds. Over time, solubilised elastin was released from the COL-EL sol scaffold as indicated by reduced Elastin-Van Gieson staining. However, at day 21 after implantation, substantial staining was still present in the scaffolds, indicating a slow release mechanism.
Blood vessels were most abundant in COL-EL sol scaffolds, both at the periphery and within the scaffold as analysed by type IV collagen staining. These scaffolds also contained more large blood vessels than COL-EL fibre and COL. In COL-EL fibre , vascularisation was considerably less. In COL, blood vessels were found only at the periphery of the scaffolds.
At day 21, COL-EL sol scaffolds showed most new rat elastin, not only in blood vessels, but also as thin elastic fibres within the scaffold. In COL-EL fibre scaffolds, new elastin was found mainly in blood vessels present in the capsule around the implant and small amounts of thin elastic fibres were sporadically found at the periphery of the scaffolds.
In COL scaffolds, rat elastin was present only in blood vessels in the capsule. In blood vessels, rat elastin co-localised with fibrillin-1 and fibrillin-2 staining, but only fibrillin-1 staining co-localised with the thin elastic fibres.
COL-EL sol scaffolds did not calcify during the time course of the experiment in contrast to COL-EL fibre scaffolds (Fig. 1) . In COL-EL fibre scaffolds, elastin fibres calcified from day 7 onwards, whereas the collagen fibrils did not. Scaffolds composed of only collagen did not calcify.
Conclusion
COL-EL sol scaffolds provide a non-calcifying release vehicle for solubilised elastin that stimulate angiogenesis and Abstracts elastic fibre formation and have great potential for soft tissue engineering.
